DOLPAC 2 DIN 02328275
Status: Marketed
Holder: VETOQUINOL N A INC
Health Canada record
| Active ingredient(s) | OXANTEL PAMOATE 111.8 MG; PYRANTEL PAMOATE 28.8 MG; PRAZIQUANTEL 10.0 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 19-Feb-2010 |
|---|
| Current status date | 19-Feb-2010 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Vetoquinol N A Inc. — licence 100448, currently licensed, last inspection rating C (2025-10-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OXANTEL PAMOATE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02328283 | DOLPAC 10 | VETOQUINOL N A INC | Tablet | OXANTEL PAMOATE 559.0 MG; PYRANTEL PAMOATE 144.0 MG; PRAZIQUANTEL 50.0 MG | Marketed |
| 02328291 | DOLPAC 25 | VETOQUINOL N A INC | Tablet | OXANTEL PAMOATE 1397.5 MG; PYRANTEL PAMOATE 360.0 MG; PRAZIQUANTEL 125.0 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 13194 | 2012-04-10 | Supplement to a New Drug Submission (SNDS) | New Indication |
| 10305 | 2009-06-29 | New Drug Submission (NDS) | |
Request a quote for DOLPAC 2
How to read a Canadian DIN record